Home/Filings/4/0001610717-24-000369
4//SEC Filing

Martell Bridget A 4

Accession 0001610717-24-000369

CIK 0001799448other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:07 PM ET

Size

5.3 KB

Accession

0001610717-24-000369

Insider Transaction Report

Form 4
Period: 2024-06-27
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-27+60,00060,000 total
    Exercise: $0.38Exp: 2034-06-27Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2025 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.

Documents

1 file

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1
  • filerCIK 0001629627

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:07 PM ET
Size
5.3 KB